Atherosclerosis 1996: Vol 122 Index

6 Pages·1996·1.4 MB·English

atherosclerosis
Atherosclerosis 122 (1996) 271-273
Author index
Volume 122 (1996)
Abernathy, J.R., see Shalnova, S. 122, 47 Evans, A.E., see Mailly, F. 122,21
Alaupovic, P., see Koren, E. 122, 105 Evans, R.W., see Sutton-TyrrelJ, K. 122, 11
Alcorn, H.G., see Sutton-Tyrrell, K. 122, 11
Anderssen, S., see Holme, I. 122, 97 Ferber, W., see Krejcy, K. 122, 59
Antonov, A., see Kolpakov, V. 122, 173 Fesmire, J., see Koren, E. 122, 105
Aro, A., see Pajukanta, P.E. 122, 1 Fisher, R.M., see Mailly, F. 122, 21
Arveiler, D., see Mailly, F. 122, 21 Fujita, K., see Hirata, F. 122, 135
Bagatell, C., see Marcovina, §.M. 122, 89 Garcia-Honduvilla, N., see Bujan, J. 122, 141
Bannykh, S., see Kolpakov, V. 122, 173 Garg, U., see Tsai, M.-Y. 122, 69
Bard, J.M., see Mailly, F. 122, 21 Grobbee, D.E., see Uiterwaal, C.§.P.M. 122, 235
Becker, C.-H., see Matthias, D. 122, 201
Bellon, J.M., see Bujan, J. 122, 141 Hallum, G., see Koren, E. 122, 105
Blangero, J., see Jaquish,C.E. 122, 117 Haffner, S.M., see Jaquish, CE. 122,117
Blundell, G., B.G. Jones, F.A. Rose, N. Tudball, Homocys- Hanson, N.Q., see Tsai, M.Y. 122, 69
teine mediated endothelial cell toxicity and its ameliora- Heli, T., see Pajukanta, P.-E. 122, |
tion 122, 163 Hiraga, T., M. Shimada, M. Okubo, K. Nakanishi, T.
Boer, J.M.A., see van de Vijver, L.P.L. 122, 245 Kobayashi, T. Murase, Lipoprotein(a) is an independent
Breithardt, G., see Schriever,C. 122, 255 risk factor for multiple cerebral infarctions 122, 29
Bremner, W.J., see Marcovina, S.M. 122, 89 Hirata, F., K. Fujita, Y. Ishikura, K. Hosoda, T. Ishikawa,
Buddecke, E., see Schriever, C. 122, 255 H. Nakamura, Hypocholesterolemic effect of sesame lignan
Bujan, J., J.M. Bellon, C. Sabater, F. Jurado, N. Garcia- in humans 122, 135
Honduvilla, B. Dominguez, E. Jorge, Modifications in- Hjermann, I., see Holme, I. 122, 97
duced by atherogenic diet in the capacity of the arterial Hofman, A., see Uiterwaal, C.S.PM. 122, 235
wall in rats to respond to surgical insult 122, 141 Holme, I., P. Urdal, S. Anderssen, I. Hjermann, Exercise-in-
duced increase in lipoprotein (a) 122, 97
Casao, E., see Pocovi, M. 122, 33 Hoppichler, F., H.G. Kraft, C. Sandholzer, M. Lechleitner,
Cenarro, A., see Pocovi, M. 122, 33 J.R. Patsch, G. Utermamn, Lipoprotein(a) is increased in
Centurion, H., see Koren, E. 122, 105 triglyceride-rich lipoproteins in men with coronary heart
Civeira, F., see Pocovi, M. 122, 33 disease, but does not change acutely following oral fat
Corder, C., see Koren, E. 122, 105 ingestion 122, 127
Cybulsky, M.I., see Krejcy, K. 122, 59 Hosoda, K., see Hirata, F. 122, 135
Hosomi, N., see Tsuda, Y. 122, 225
Davis, C.E., see Shalnova, S. 122, 47 Humphries, S.E., see Mailly, F. 122, 21
de Bruijn, A.M., see Uiterwaal, CS.P.M. 122, 235
Deev, A., see Shalnova, §. 122, 47 Ishikawa, T., see Hirata, F. 122, 135
Dominguez, B., see Bujan, J. 122, 141 Ishikura, Y., see Hirata, F. 122, 135
Izumi, Y., see Tsuda, Y. 122, 225
Ekelund, L.-G., see Shalnova,S. 122, 47
Esteban, M., see Pocovi,M. 122, 33 Jaakkola, O., see Tertov, V-V. 122, 191
272 Author index vol. 122 (1996)
Jaquish, C.E., M.C. Mahaney, J. Blangero, S.M. Haffner, McConathy, W.D., see Koren, E. 122, 105
M.P. Stern, J.W. MacClwuer, Genetic correlations between Meilahn, E., see Sutton-Tyrrell, K. 122, 11
lipoprotein phenotypes and indicators of sex hormone lev- Mironov, A., see Kolpakov, V. 122, 173
els in Mexican Americans 122, 117 Mueller, G., see Koren, E. 122, 105
Jones, B.G., see Blundell, G. 122, 163 Murase, T., see Hiraga, T. 122, 29
Jorge, E., see Bujan, J. 122, 141 Myers, R.H., see Pocovi, M. 122, 33
Jurado, F., see Bujan, J. 122, 141
Nakamura, H., see Hirata, F. 122, 135
Key, N.S., see Tsai, M.Y. 122, 69 Nakanishi, K., see Hiraga, T. 122, 29
Kindling, P.H., see Matthias, D. 122, 201 Nakano, M., see Wada, K. 122, 217
Kitadai, M., see Tsuda, Y. 122, 225 Nakashima, M., see Wada, K. 122, 217
Kobayashi, T., see Hiraga, T. 122, 29 Nicaud, V., see Mailly, F. 122, 21
Kolpakov, V., R. Polishchuk, S. Bannykh, M.R.P. Solovjev, NikkKari, T., see Tertov, V.V. 122, 191
Y. Romanov, E. Tararak, A. Antonov, A. Mironov, Nishiyama, H., see Wada, K. 122, 217
Atherosclerosis-prone branch regions in human aorta: Nuotio, 1.0., K.V.K. Porkka, O.T. Raitakari, T. Lehtimaki,
microarchitecture and cell composition of intima 122, 173 J. Marniemi, S. Taimela, L. Suurinkeroinen, J.S.A. Vi-
Koren, E., C. Corder, G. Mueller, H. Centurion, G. Hallum, ikari, Prevalence of hyperapobetalipoproteinemia and fac-
J. Fesrmire, W.D. McConathy, P. Alaupovic, Triglyceride tors affecting the phenotype expression in children and
enriched lipoprotein particles correlate with the severity of young adults. The Cardiovascular Risk in Young Finns
coronary artery disease 122, 105 Study 122, 79
Kraft, H.G., see Hoppichler, F. 122, 127
Krauss, X.H., see Uiterwaal,C.S.P.M. 122, 235 Okubo, M., see Hiraga, T. 122, 29
Krejcy, K., S. Schwarzacher, W. Ferber, C. Plesch, M.I. Ordovas, J.M., see Pocovi, M. 122, 33
Cybulsky, F.F. Weidinger, Expression of VCAM-1 in rab- Orekhov, A.N., see Tertov, V.V. 122, 191
bit iliac arteries is associated with vasodilator dysfunction
of regenerated endothelium following balloon injury 122, Pajukanta, P.E., L.M. Valsta, A. Aro, P. Pietinen, T. Helid,
59 M.J. Tikkanen, The effects of the apolipoprotein B signal
Kruijssen, D.A.C.M., see van de Vijver, L.P.L. 122, 245 peptide (ins /del) and XbaI polymorphisms on plasma lipid
responses to dietary change 122, |
Lahdenpera, S., J. Puolakka, T. PyGrala, H. Luotola, M.-R. Patsch, J.R., see Hoppichler, F. 122, 127
Taskinen, Effects of postmenopausal estrogen/progestin re- Pietinen, P., see Pajukanta, P.E. 122, 1
placement therapy on LDL particles; comparison of trans- Plavinskaya, S., see Shalnova, S. 122, 47
dermal and oral treatment regimens 122, 153 Plesch, C., see Krejcy, K. 122, 59
Lechleitner, M., see Hoppichler, F. 122, 127 Pocovi, M., A. Cenarro, F. Civeira, R.H. Myers, E. Casao,
Lehtimaki, T., see Nuotio, LO. 122, 79 M. Esteban, J.M. Ordovas, Incomplete dominance of type
Lippi, G-, see Marcovina, S.M. 122, 89 III hyperlipoproteinemia is associated with the rare
Luc, G., see MailJy, F. 122, 21 apolipoprotein E2 (Arg136— Ser) variant in multigenera-
Luong, L.-A., see Mailly, F. 122, 21 tional pedigree studies 122, 33
Luotola, H., see Lahdenpera, S. 122, 153 Poirier, O., see Mailly, F. 122, 21
Polishchuk, R., see Kolpakov, V. 122, 173
MacCluer, J.W., see Jaquish, C.E. 122, 117 Porkka, K.V.K., see Nuotio, I.O. 122, 79
Mahaney, M.C., see Jaquish,C.E. 122, 117 Princen, H.M.G., see van de Vijver, L.P.L. 122, 245
Mailly, F., R.M. Fisher, V. Nicaud, L-A. Luong, A.E. Puolakka, J., see Lahdenperad, S. 122, 153
Evans, P. Marques-Vidal, G. Luc, D. Arveiler, J.M. Bard, Pyorala, T., see Lahdenperad, S. 122, 153
Association between the LPL-D9N mutation in the lipo-
protein lipase gene and plasrna lipid traits in myocardial Raitakari, O.T., see Nuotio, I.O. 122, 79
infarction survivors from the ECTIM study Riezler, R., see Matthias, D. 122, 201
122, 21 Romanov, Y., see Kolpakov, V. 122, 173
Marcovina, S.M., G. Lippi, C. Bagatell, WJ. Bremner, Rose, F.A., see Blundell, G. 122, 163
Testosterone-induced suppression of lipoprotein(a) in nor-
mal men; relation to basal lipoproteinga) level 122, 89 Sabater, C., see Bujan, J. 122, 141
Marniemi, J., see Nuotio, J.0. 122, 79 Sandholzer, C., see Hoppichler, F. 122, 127
Marques-Vidal, P_, see Mailly, F. 122, 21 Saniabadi, A.R., see Wada, K. 122, 217
Matthias, D., C.-H. Beckers, R. Riezler, P.H- Kindling, Ho- Satoh, K., see Tsuda, Y. 122, 225
mocysteine induced arteriosclerosis-like alterations of the Schmidt, A., see Schriever, C. 122, 255
aorta iN normotensive and hypertensive rats following ap- Schriever, C., A. Schmidt, G. Breithardt, E. Buddecke, Hu-
plication of high doses of methionine 122, 201 man recombinant insulin-like growth factor I and -II stimu-
Author index vol. 122 (1996) 273
late the expression of basic fibroblast growth factor but Schwichtenberg, Molecular and biochemical approaches in
suppress the division of bovine coronary smooth muscle the identification of heterozygotes for homocystin-
cells 122, 255 uria 122, 69
Schwarzacher, S., see Krejcy, K. 122, 59
Schwichtenberg, K., see Tsai, M.Y. 122, 69 Tsuda, Y., K. Satoh, M. Kitadai,T .T akahashi, Y. Izumi, N.
Seidell, J.C., see van de Vijver, L.P.L. 122, 245 Hosomi, Effects of pravastatin sodium and simvastatin on
Shalnova, S., D.B. Shestov, L.-G. Ekelund, J.R. Abernathy, plasma fibrinogen level and blood rheology in type II
S. Plavinskaya, R.P. Thomas, D.H. Williams, A. Deev, hyperlipoproteinemia 122, 225
C.E. Davis, Blood pressure and heart rate response during
Tudball, N., see Blundell, G. 122, 163
exercise in men and women in the USA and Russia lipid
research clinics prevalence study 122, 47 Uiterwaal, C.S.P.M., J.C.M. Witteman, W.-A.H.J. van
Shestov, D.B., see Shalnova, S. 122, 47 Stiphout, X.H. Krauss, A.M. de Bruijn, A. Hofman, D.E.
Shimada, M., see Hiraga, T. 122, 29 Grobbee, Lipoproteins and apolipoproteins in the young
Sobenin, I.A., see Tertov, V.V. 122, 191 and familial risk of coronary atherosclerosis 122, 235
Solakivi, T., see Tertov, V.V. 122, 191 Umemura, K., see Wada, K. 122, 217
Solovjev, M.R.P., see Kolpakov, V. 122, 173 Urdal, P., see Holme, I. 122, 97
Stern, M.P., see Jaquish, C.E. 122, 117
Utermann, G., see Hoppichler, F. 122, 127
Steyger, R., see van de Vijver, L.P.L. 122, 245
Suh, A., see Tsai, M.Y. 122, 69 van de Vijver, L.P.L., R. Steyger, G. van Poppel, J.M.A.
Sutton-Tyrrell, K., R.W. Evans, E. Meilahn, H.G. Alcorn, Boer, D.A.C.M. Kruijssen, J.C. Seidell, H.M.G. Princen,
Lipoprotein(a) and peripheral atherosclerosis in older Autoantibodies against MDA-LDL in subjects with severe
adults 122, 11 and minor atherosclerosis and healthy population con-
Suurinkeroinen, L., see Nuotio, 1.0. 122, 79 trols 122, 245
van Poppel, G., see van de Vijver, L.P.L. 122, 245
Taimela, S., see Nuotio, 1.0. 122, 79 van Stiphout, W.-A.H.J., see Uiterwaal, C.S.P.M. 122, 235
Takahashi, T., see Tsuda, Y. 122, 225 Valsta, L.M., see Pajukanta, P.E. 122, 1
Takiguchi, Y., see Wada, K. 122, 217 Viikari, J.S.A., see Nuotio, IO. 122, 79
Talmud, P.J., see Mailly, F. 122, 21
Tararak, E., see Kolpakov, V. 122, 173 Wada, K., K. Umemura, H. Nishiyama, A.R. Saniabadi, Y.
Taskinen, M.-R., see Lahdenperd, S. 122, 153 Takiguchi, M. Nakano, M. Nakashima, A chemilumines-
cent detection of superoxide radical produced by adherent
Tertov, V.V., LA. Sobenin, A.N. Orekhov, O. Jaakkola, T.
Solakivi, T. Nikkari, Characteristics of low density lipo- leucocytes to the subendothelium following thrombolysis:
protein isolated from circulating immune complexes 122, studies with a photochemically induced thrombosis model
191 in the guinea pig femoral artery. 122, 217
Thomas, R.P., see Shalnova, S. 122, 47 Weidinger, F.F., see Krejcy, K. 122, 59
Tikkanen, M.J., see Pajukanta, P.E. 122, 1 Williams, D.H., see Shalnova, S. 122, 47
Tsai, M.Y., U. Garg, N.S. Key, N.Q. Hanson, A. Suh, K. Witteman, J.C.M., see Uiterwaal, C.S.P.M. 122, 235

Atherosclerosis 122 (1996) 275-276
Subject index
Volume 122 (1996)
Adventitia 122, 141 Endothelium 122, 173, 59
Alcohol 122, 79 Estrogens 122, 153
Allopurinol 122, 163 Exercise 122, 47, 97
Amplification refractory mutation system 122, 69 Exogenous testosterone 122, 89
Aortic wall 122, 201 Expression of fibroblast growth factor 122, 255
Apolipoprotein(a) 122, 127
Apolipoprotein(a) isoform 122, 89 Family 122, 235
Apolipoprotein B signal peptide polymorphism 122, 1 Fibrinogen 122, 225
Apolipoprotein B XbaI polymorphism 122, 1
122, 117, 33
Apolipoprotein E 122, 33 Genetics
122, 69
Apolipoproteins 122, 105, 235 Genetic variants
Atherogenesis 122, 141 Glutathione 122, 163
Atheroma plaques 122, 141 Guinea pig femoral artery 122, 217
Atherosclerosis 122,11, 173, 201, 245
Autoantibodies 122, 245 Heart rate 122, 47
Autoantigen 1422, 19] Hemodynamics 122, 173
Heparan sulfate 122, 255
Blood pressure 122, 47 High-density lipoprotein cholesterol 122, 117
Homocysteine 122, 163, 201
Cardiovascular diseases 122, 245 Homocystinuria 122, 69
122, 173
Carotid stenosis 122,11 Human aorta
Case-control 122, 21 Hyperapobetalipoproteinemia 122, 79
Chemiluminescence 122, 217 Hypercholesterolemia 122, 135
Children 122, 79
Hyperhomocyst(e)inemia 122, 69
Circulating immune consplexes 122, 191 Hyperlipoproteinemia 122, 33
Coronary 122, 235 Hyperlipoproteinemia, type I] 122, 225
Coronary artery disease 122, 105 Hypertension 122, 29
Coronary smooth muscle cells 122, 255
122, 173
Cystathionine f-synthase 122, 69 Immunohistochemistry
Insulin-like growth factor 122, 255
Dehydroepiandrosterone sulfate 122, 117 Intima] hyperplasia 122, 141
Density gradient ulttacentrifugation 122, 127
Desialylated LDL 122, 191 LDL oxidation 122, 245
Dietary intervention 122, 97 LDL subclasses 122, 153
Diet response 122, 1 Leucocyte 122, 217
122, 97
DNA _ 122, 163 Lifestyle alteration
Light and electron microscopy 122, 201
ECTIM 122 21
Lignan 122, 135
122, 79, 105
Eicosanoids 122, 163 Lipids
122,
Electron microscopy 122, 173 Lipoprotein(a) 1], 29, 127
122, 97
Endothelial cells 122, 163 Lipoprotein a
276 Subject index vol. 122 (1996)
Lipoprotein(a) concentration 122, 89 Radicals 122, 163
Lipoprotein lipase gene mutation 122, 21 Rat 122, 201
Lipoprotein particles 122, 105 Rats 122, 141
Lipoproteins 122, 33, 79, 105, 153 Reocclusion after thrombolysis 122, 217
Low density lipoprotein (LDL) 122, 191 rt-PA 122, 217
Russia 122, 47
MCLA 122, 217
Scavengers 122, 163
Methionine 122, 201
Sesamin 122, 135
Mitochondria 122, 201
Sex hormone-binding globulin 122, 117
Mortality 122, 47
Sialylated LDL 122, 191
Multiple cerebral infarctions 122, 29
Simvastatin 122, 225
Non-insulin-dependent diabetes mellitus 122, 29 Smoking 122, 79
Smooth muscle cells 122, 173
Superoxide radical 122, 217
Obesity 122, 21
Oral contraceptives 122, 79
Triglyceride-rich lipoproteins 122, 127
Triglycerides 122, 117
Peripheral vascular disease 122, 11
Photochemical reaction 122, 217 USA 122, 47
Plasma triglycerides 122, 21
Postprandial lipoprotein metabolism 122, 127 Vascular injury 122, 59
Pravastatin sodium 122, 225 Vasodilation 122, 59
Progestins 122, 153 VCAM-1_ 122, 59